SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BMcV who wrote (3208)6/4/1999 10:14:00 AM
From: Don Miller  Read Replies (1) of 10280
 
S-3 application just arrived- corporate-ir.net

An abstract

"On December 15, 1998, Sepracor Inc. issued and sold $300,000,000 principal
amount of 7% Convertible Subordinated Debentures due 2005 in a private offering.
This prospectus relates to the resale of the debentures and the shares of common
stock into which the debentures are convertible. All securities offered by this
prospectus are offered by selling securityholders. The principal terms of the
debentures include the following:



<TABLE>
<S> <C>
- Interest:.............................. accrues from December 10, 1998 at the rate of
7% per year, payable semi-annually on each
June 15 and December 15, beginning June 15,
1999

- Maturity Date:......................... December 15, 2005, unless earlier redeemed

- Conversion Rate:....................... $124.875 in principal amount per share of
common stock, subject to adjustment

- Subordination.......................... effectively subordinated to all Indebtedness
and liabilities of Sepracor; no restriction
on incurrence of additional Indebtedness

- Redemption............................. redeemable at certain times and under certain
circumstances by Sepracor or the holders"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext